STOCK TITAN

Ametek, Inc. 10-Q Filings

AME NYSE

Every 10-Q that Ametek, Inc. (AME) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow AME and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AME filings page.

Rhea-AI Summary

AMETEK, Inc. delivered record Q2 2026 results, with net sales of $2,044.4 million, up 15.0%, and net income of $406.9 million. Diluted EPS rose to $1.77. Organic sales grew 10% and acquisitions added 5%, while orders reached $2,284.0 million and backlog hit $4,110.2 million.

Both EIG and EMG segments posted double‑digit sales growth and higher margins when excluding acquisition‑related dilution and $16.2 million of integration costs. For the first half, revenue was $3,972.8 million and free cash flow $877.7 million, reducing the net debt‑to‑capital ratio to 12.0%.

The company closed the LKC and First Aviation acquisitions and agreed to acquire Indicor Instrumentation in an all‑cash $5.0 billion deal adding about $1.1 billion of annual sales. New $3.5 billion revolver capacity and a $4.0 billion term‑loan facility are in place to finance Indicor and support future needs.

Rhea-AI Summary

AMETEK delivered strong first-quarter 2026 growth with record profitability and backlog. Net sales rose 11.3% to $1.93 billion, driven by 5% organic growth, 4% from acquisitions and a 2% currency tailwind. Segment operating income increased 12.8% to $544.7 million, and consolidated operating margin improved to 26.7%.

Net income grew 13.5% to $399.4 million, with diluted EPS up 14.5% to a record $1.74. Orders jumped 23.3% to $2.22 billion and backlog reached a record $3.87 billion, supporting future revenue. EMG posted particularly strong margin expansion, while EIG absorbed dilution from recent acquisitions.

Operating cash flow increased to $451.5 million and free cash flow reached $426.0 million, funding $209.6 million for the LKC acquisition, higher dividends after a 10% dividend increase, and share repurchases. Net debt declined, with the net debt‑to‑capital ratio improving to 13.4% and significant undrawn revolver capacity remaining.

Rhea-AI Summary

AMETEK (AME) reported record Q3 2025 results, with net sales of $1,892.6 million, up 10.8% year over year. Operating income reached $488.4 million and diluted EPS rose to $1.60, up 8.8%. Net income was $371.4 million. Orders were a record $1,967.8 million and backlog stood at a record $3,546.3 million.

Segment performance was solid. EIG sales increased to $1,246.3 million, aided by acquisitions, while EMG sales grew to $646.3 million on 12% organic growth. Reported margins reflected acquisition mix and one‑time costs; excluding these effects, margins expanded on Operational Excellence benefits.

Year to date, net sales were $5,402.7 million and operating income was $1,404.8 million. The company closed FARO and Kern, deploying $933.2 million in cash, and ended the quarter with $439.2 million in cash and $2,464.2 million in total debt, including $635.0 million outstanding under the commercial paper program. Free cash flow was $1,144.2 million for the first nine months, and the quarterly dividend was raised to $0.31 per share.

Rhea-AI Summary

AMETEK (AME) reported another record quarter for Q2 2025. Net sales rose 2.5 % YoY to $1.78 bn, driven by 2 % contribution from acquisitions and 1 % favourable FX. Operating income increased 3.2 % to $461.6 m, lifting the operating margin to 26.0 % (25.8 % prior year). Net income advanced 6.1 % to $358.4 m and diluted EPS grew 6.9 % to $1.55. Orders climbed 6.3 % to $1.78 bn and backlog reached $3.47 bn, underpinning future revenue. Segment mix was favourable: Electromechanical Group sales +6.4 % with a 260 bp underlying margin gain, while Electronic Instruments Group faced a 3 % organic decline offset by M&A and FX.

Balance-sheet strength improved. Operating cash flow was $776.6 m (-1.9 %), free cash flow $724.3 m. Cash rose to $619.7 m and net debt fell to $1.94 bn, cutting the net-debt-to-capital ratio to 11.3 %. Lower leverage reduced interest expense 45 % to $16.9 m. The dividend was lifted 11 % to $0.31 per share and $18.1 m of stock was repurchased. AMETEK deployed $104 m for the Kern acquisition and, post-quarter, closed the $920 m purchase of FARO Technologies (c.$340 m annual sales) to bolster its Electronic Instruments portfolio. Management continues to target margin expansion via Operational Excellence while cautioning on tariff and FX headwinds.